Atrial Fibrillation in Beta-Thalassemia
NCT05508932 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2026-02-24
Summary
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
Conditions
Sponsors & Collaborators
-
University Hospital of Ferrara
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2032-06-01
- Completion
- 2032-07-01
Countries
- Italy
Study Locations
More Related Trials
-
Genetic Variants Affecting the Clinical Severity of Beta Thalassemia
NCT04918056 ·Status: UNKNOWN
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT02428023 ·Status: UNKNOWN
-
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
NCT01496963 ·Status: COMPLETED
-
Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia
NCT05494333 ·Status: UNKNOWN
-
The Role of OCTA in Patients Affected by Beta Thalassemia
NCT04582110 ·Status: COMPLETED
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Genetic Factors Affecting the Severity of Beta Thalassemia
NCT00159042 ·Status: COMPLETED
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox
NCT03358498 ·Status: UNKNOWN
-
Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload
NCT00560820 ·Status: COMPLETED ·Phase: PHASE1
-
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
NCT00480506 ·Status: COMPLETED
-
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871 ·Status: COMPLETED
-
Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes
NCT02855957 ·Status: COMPLETED ·Phase: NA
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care
NCT02626689 ·Status: COMPLETED
-
Thrombin Generation in Beta-thalassemia Major
NCT04962984 ·Status: UNKNOWN ·Phase: NA
-
Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
NCT03947632 ·Status: COMPLETED
-
International Registry of Patients With Alpha Thalassemia
NCT04872179 ·Status: RECRUITING
-
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
NCT00800761 ·Status: COMPLETED ·Phase: PHASE4
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients
NCT03992001 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
NCT00564941 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19
NCT04746066 ·Status: RECRUITING